• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development.在哺乳动物发育过程中,具有强大细胞毒性的自然杀伤细胞最初从红细胞-髓样祖细胞中出现。
Dev Cell. 2020 Apr 20;53(2):229-239.e7. doi: 10.1016/j.devcel.2020.02.016. Epub 2020 Mar 19.
2
Erythro-myeloid progenitors: "definitive" hematopoiesis in the conceptus prior to the emergence of hematopoietic stem cells.红骨髓祖细胞:在造血干细胞出现之前,胚胎中的“确定性”造血。
Blood Cells Mol Dis. 2013 Dec;51(4):220-5. doi: 10.1016/j.bcmd.2013.09.006. Epub 2013 Oct 2.
3
Hlf marks the developmental pathway for hematopoietic stem cells but not for erythro-myeloid progenitors.Hlf 标记造血干细胞的发育途径,但不标记红系-髓系祖细胞。
J Exp Med. 2019 Jul 1;216(7):1599-1614. doi: 10.1084/jem.20181399. Epub 2019 May 10.
4
Erythro-myeloid progenitors can differentiate from endothelial cells and modulate embryonic vascular remodeling.红骨髓祖细胞可从血管内皮细胞分化而来,并调节胚胎血管重塑。
Sci Rep. 2017 Mar 8;7:43817. doi: 10.1038/srep43817.
5
Adult Connective Tissue-Resident Mast Cells Originate from Late Erythro-Myeloid Progenitors.成人结缔组织驻留肥大细胞起源于晚期红-髓系祖细胞。
Immunity. 2018 Oct 16;49(4):640-653.e5. doi: 10.1016/j.immuni.2018.09.023.
6
Distinct Sources of Hematopoietic Progenitors Emerge before HSCs and Provide Functional Blood Cells in the Mammalian Embryo.造血祖细胞的不同来源在造血干细胞之前出现,并在哺乳动物胚胎中提供功能性血细胞。
Cell Rep. 2015 Jun 30;11(12):1892-904. doi: 10.1016/j.celrep.2015.05.036. Epub 2015 Jun 18.
7
Prolactin Acts on Myeloid Progenitors to Modulate SMAD7 Expression and Enhance Hematopoietic Stem Cell Differentiation into the NK Cell Lineage.催乳素作用于髓系祖细胞调节 SMAD7 表达并增强造血干细胞向 NK 细胞谱系分化。
Sci Rep. 2020 Apr 14;10(1):6335. doi: 10.1038/s41598-020-63346-4.
8
Single-cell RNA sequencing-guided fate-mapping toolkit delineates the contribution of yolk sac erythro-myeloid progenitors.单细胞 RNA 测序指导的命运图谱工具包描绘了卵黄囊红髓祖细胞的贡献。
Cell Rep. 2023 Nov 28;42(11):113364. doi: 10.1016/j.celrep.2023.113364. Epub 2023 Nov 3.
9
Distinct temporal requirements for Runx1 in hematopoietic progenitors and stem cells.Runx1 在造血祖细胞和干细胞中有不同的时间要求。
Development. 2013 Sep;140(18):3765-76. doi: 10.1242/dev.094961. Epub 2013 Aug 7.
10
The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis.巨核细胞系起源于成血管细胞前体,是原始造血和定形造血的一个组成部分。
Blood. 2007 Feb 15;109(4):1433-41. doi: 10.1182/blood-2006-06-031898. Epub 2006 Oct 24.

引用本文的文献

1
RAG recombinase expression discriminates the development of natural killer cells.RAG重组酶的表达区分自然杀伤细胞的发育。
Front Immunol. 2025 Jul 25;16:1607664. doi: 10.3389/fimmu.2025.1607664. eCollection 2025.
2
Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity.携带CCL19、CCR2B、高亲和力CD16、IL-15和NKG2D复合物的人诱导多能干细胞衍生的自然杀伤细胞增强抗实体瘤活性。
Stem Cell Res Ther. 2025 Jul 15;16(1):373. doi: 10.1186/s13287-025-04461-9.
3
Engineered iPSC-derived natural killer cells: recent innovations in translational innate anti-cancer immunotherapy.工程化诱导多能干细胞衍生的自然杀伤细胞:转化性先天性抗癌免疫疗法的最新创新
Clin Transl Immunology. 2025 Jul 10;14(7):e70045. doi: 10.1002/cti2.70045. eCollection 2025.
4
Pluripotent stem cell-based immunotherapy: advances in translational research, cell differentiation, and gene modifications.基于多能干细胞的免疫疗法:转化研究、细胞分化和基因修饰的进展
Life Med. 2025 Jan 18;4(1):lnaf002. doi: 10.1093/lifemedi/lnaf002. eCollection 2025 Feb.
5
Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non-Viral CAR-NK Cell Engineering.革新癌症免疫疗法:非病毒CAR-NK细胞工程的进展与前景
Cell Prolif. 2025 Apr;58(4):e13791. doi: 10.1111/cpr.13791. Epub 2024 Dec 27.
6
Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy.诱导多能干细胞来源的自然杀伤细胞疗法的进展
Cells. 2024 Nov 29;13(23):1976. doi: 10.3390/cells13231976.
7
The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development.白血病发展过程中克隆进化、分化层次和个体发生的交叉点
Blood Cancer Discov. 2025 Mar 4;6(2):94-109. doi: 10.1158/2643-3230.BCD-24-0235.
8
Natural Killer Cells in Cancers of Respiratory System and Their Applications in Therapeutic Approaches.自然杀伤细胞在呼吸系统癌症中的作用及其在治疗方法中的应用。
Immun Inflamm Dis. 2024 Nov;12(11):e70079. doi: 10.1002/iid3.70079.
9
Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities.两种分化策略来源的 iPSC-NK 细胞的比较分析揭示了不同的特征和细胞毒性活性。
Front Immunol. 2024 Oct 9;15:1463736. doi: 10.3389/fimmu.2024.1463736. eCollection 2024.
10
Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis.高效生成表达人 NOTCH 配体的造血内皮细胞,作为体外造血和淋巴发生的基础。
Nat Commun. 2024 Sep 4;15(1):7698. doi: 10.1038/s41467-024-51974-7.

本文引用的文献

1
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice.高维单细胞分析鉴定人类和小鼠组织特异性特征和保守 NK 细胞亚群。
Immunity. 2018 Nov 20;49(5):971-986.e5. doi: 10.1016/j.immuni.2018.09.009. Epub 2018 Nov 6.
2
RUNX1 and the endothelial origin of blood.RUNX1与血液的内皮起源
Exp Hematol. 2018 Dec;68:2-9. doi: 10.1016/j.exphem.2018.10.009. Epub 2018 Oct 31.
3
NK cell therapy for hematologic malignancies.用于血液系统恶性肿瘤的自然杀伤细胞疗法。
Int J Hematol. 2018 Mar;107(3):262-270. doi: 10.1007/s12185-018-2407-5. Epub 2018 Jan 27.
4
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells.从人多能干细胞定向分化原始和定型造血祖细胞。
J Vis Exp. 2017 Nov 1(129):55196. doi: 10.3791/55196.
5
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.CD56bright自然杀伤细胞在白细胞介素-15启动后表现出强大的抗肿瘤反应。
J Clin Invest. 2017 Nov 1;127(11):4042-4058. doi: 10.1172/JCI90387. Epub 2017 Oct 3.
6
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.异基因自然杀伤细胞作为癌症免疫治疗平台的兴起:近期创新与未来发展
Front Immunol. 2017 May 31;8:631. doi: 10.3389/fimmu.2017.00631. eCollection 2017.
7
Transcriptome analysis reveals similarities between human blood CD3 CD56 cells and mouse CD127 innate lymphoid cells.转录组分析揭示了人类血液 CD3 CD56 细胞与小鼠 CD127 固有淋巴细胞之间的相似性。
Sci Rep. 2017 Jun 14;7(1):3501. doi: 10.1038/s41598-017-03256-0.
8
Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4.多能干细胞向人类终末造血细胞的定向分化受中胚层中CDX4表达的调控。
Blood. 2017 Jun 1;129(22):2988-2992. doi: 10.1182/blood-2016-11-749382. Epub 2017 Apr 13.
9
A view of human haematopoietic development from the Petri dish.从培养皿看人类造血发育。
Nat Rev Mol Cell Biol. 2017 Jan;18(1):56-67. doi: 10.1038/nrm.2016.127. Epub 2016 Nov 23.
10
Differentiation of human embryonic stem cells to HOXA hemogenic vasculature that resembles the aorta-gonad-mesonephros.人胚胎干细胞向类似于主动脉-性腺-中肾的 HOXA 血发生血管的分化。
Nat Biotechnol. 2016 Nov;34(11):1168-1179. doi: 10.1038/nbt.3702. Epub 2016 Oct 17.

在哺乳动物发育过程中,具有强大细胞毒性的自然杀伤细胞最初从红细胞-髓样祖细胞中出现。

Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development.

机构信息

Department of Medicine, Division of Hematology, Washington University in St Louis, St. Louis, MO 63110, USA.

Center for Pediatric Biomedical Research and Department of Pediatrics, University of Rochester, Rochester, NY 14642, USA.

出版信息

Dev Cell. 2020 Apr 20;53(2):229-239.e7. doi: 10.1016/j.devcel.2020.02.016. Epub 2020 Mar 19.

DOI:10.1016/j.devcel.2020.02.016
PMID:32197069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7185477/
Abstract

Natural killer (NK) cells are a critical component of the innate immune system. However, their ontogenic origin has remained unclear. Here, we report that NK cell potential first arises from Hoxa KitCD41CD16/32 hematopoietic-stem-cell (HSC)-independent erythro-myeloid progenitors (EMPs) present in the murine yolk sac. EMP-derived NK cells and primary fetal NK cells, unlike their adult counterparts, exhibit robust degranulation in response to stimulation. Parallel studies using human pluripotent stem cells (hPSCs) revealed that HOXA CD34 progenitors give rise to NK cells that, similar to murine EMP-derived NK cells, harbor a potent cytotoxic degranulation bias. In contrast, hPSC-derived HOXA CD34 progenitors, as well as human cord blood CD34 cells, give rise to NK cells that exhibit an attenuated degranulation response but robustly produce inflammatory cytokines. Collectively, our studies identify an extra-embryonic origin of potently cytotoxic NK cells, suggesting that ontogenic origin is a relevant factor in designing hPSC-derived adoptive immunotherapies.

摘要

自然杀伤 (NK) 细胞是先天免疫系统的重要组成部分。然而,其发生来源仍不清楚。在这里,我们报告说,NK 细胞潜能首先源自存在于鼠卵黄囊中造血干细胞 (HSC) 独立的红系-髓系祖细胞 (EMPs)。与成年 NK 细胞不同,源自 EMP 的 NK 细胞和原代胎儿 NK 细胞在受到刺激时表现出强烈的脱颗粒反应。使用人类多能干细胞 (hPSC) 的平行研究表明,HOXA CD34 祖细胞产生的 NK 细胞与鼠源性 EMP 衍生的 NK 细胞相似,具有强大的细胞毒性脱颗粒偏向。相比之下,hPSC 衍生的 HOXA CD34 祖细胞以及人脐带血 CD34 细胞产生的 NK 细胞表现出较弱的脱颗粒反应,但可强烈产生炎症细胞因子。总的来说,我们的研究确定了具有强大细胞毒性的 NK 细胞的胚胎外起源,这表明发生来源是设计 hPSC 衍生过继免疫疗法的一个相关因素。